LOGO
LOGO

Dr. Reddy's Laboratories Launches Finrid In India

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Dr. Reddy's Laboratories launched Finrid (Fentanyl Transdem Patch) in India. It is used to treat severe to moderate pain, and provides continuous systemic delivery of Fentanyl, a potent opioid analgesic for up to 72 hours. It is the first opioid transdermal patch to be developed in India.

Being a controlled substance, Finrid will be sold through an independent distribution structure and will be available across hospitals and palliative care centers in India. Finrid is available in a transdermal patch form, and delivers dosages of 25 meg/hr and 50 mcg/hr depending on the patch used.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19